CIK 0001764013 · Large accelerated filer
Immunovant, Inc.
Sign in to watch- Ticker
- IMVT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832771572
- Phone
- 917-410-3120
- Business address
- 1000 PARK FORTY PLAZA, DURHAM, NC, 27713
- Former names
- Health Sciences Acquisitions Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,030,805
- in 10 filings, $173K under 10b5-1 plans
Net −$1,030,805. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-28 | Girao Tiago Chief Financial Officer | Sale | −6,606 | $28.50 | $188K | 234,192 |
| 2026-07-23 | Girao Tiago Chief Financial Officer | Sale | −6,798 | $38.69 | $263K | 240,798 |
| 2026-06-26 | Girao Tiago Chief Financial Officer | Option exercise | +10,000 | $15.90 | $159K | 257,596 |
| 2026-06-26 | Girao Tiago Chief Financial Officer | Sale | −10,000 | $38.46 | $385K | 247,596 |
| 2026-06-26 | Girao Tiago Chief Financial Officer | Option exercise · Stock Option (right to buy) | −10,000 | 283,505 | ||
| 2026-04-23 | Girao Tiago Chief Financial Officer | Sale | −25,760 | $29.62 | $763K | 247,596 |
| 2026-04-07 | Girao Tiago Chief Financial Officer | Grant or award | +64,968 | 273,356 | ||
| 2026-04-07 | Girao Tiago Chief Financial Officer | Grant or award · Stock Option (right to buy) | +94,002 | 94,002 | ||
| 2025-05-01 | Girao Tiago Chief Financial Officer | Grant or award | +208,388 | 208,388 | ||
| 2025-05-01 | Girao Tiago Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +293,505 | 293,505 |
Page 1 of 1 · 10 trades